Removal of Six Estrogenic Endocrine-Disrupting Compounds (EDCs) from Municipal Wastewater Using Aluminum Electrocoagulation by Cook, Monica M. et al.
University of South Florida
Scholar Commons
Marine Science Faculty Publications College of Marine Science
4-1-2016
Removal of Six Estrogenic Endocrine-Disrupting
Compounds (EDCs) from Municipal Wastewater
Using Aluminum Electrocoagulation
Monica M. Cook
University of South Florida
Erin M. Symonds
University of South Florida, esymonds@mail.usf.edu
Bert Gerber
Gerber Pumps International, Inc.
Armando Hoare
University of South Florida, ahoare2@usfsp.edu
Edward S. Van Vleet
University of South Florida
See next page for additional authors
Follow this and additional works at: https://scholarcommons.usf.edu/msc_facpub
Part of the Environmental Sciences Commons, and the Oceanography and Atmospheric Sciences
and Meteorology Commons
This Article is brought to you for free and open access by the College of Marine Science at Scholar Commons. It has been accepted for inclusion in
Marine Science Faculty Publications by an authorized administrator of Scholar Commons. For more information, please contact
scholarcommons@usf.edu.
Scholar Commons Citation
Cook, Monica M.; Symonds, Erin M.; Gerber, Bert; Hoare, Armando; Van Vleet, Edward S.; and Breitbart, Mya, "Removal of Six
Estrogenic Endocrine-Disrupting Compounds (EDCs) from Municipal Wastewater Using Aluminum Electrocoagulation" (2016).
Marine Science Faculty Publications. 249.
https://scholarcommons.usf.edu/msc_facpub/249
Authors
Monica M. Cook, Erin M. Symonds, Bert Gerber, Armando Hoare, Edward S. Van Vleet, and Mya Breitbart
This article is available at Scholar Commons: https://scholarcommons.usf.edu/msc_facpub/249
water
Article
Removal of Six Estrogenic Endocrine-Disrupting
Compounds (EDCs) from Municipal Wastewater
Using Aluminum Electrocoagulation
Monica M. Cook 1, Erin M. Symonds 1, Bert Gerber 2, Armando Hoare 3, Edward S. Van Vleet 1
and Mya Breitbart 1,*
1 College of Marine Science, University of South Florida, Saint Petersburg, FL 33701, USA;
mmion@mail.usf.edu (M.M.C.); esymonds@mail.usf.edu (E.M.S.); vanvleet@usf.edu (E.S.V.V.)
2 Gerber Pumps International, Inc., Longwood, FL 32750, USA; bert@gerberpumps.com
3 College of Arts & Sciences, University of South Florida Saint Petersburg, Saint Petersburg, FL 33701, USA;
ahoare2@mail.usf.edu
* Correspondence: mya@usf.edu; Tel.: +1-727-553-3520
Academic Editor: Jiangyong Hu
Received: 9 January 2016; Accepted: 28 March 2016; Published: 1 April 2016
Abstract: Conventional wastewater treatment plant (WWTP) processes are primarily designed to
reduce the amount of organic matter, pathogens, and nutrients from the incoming influent. However,
these processes are not as effective in reducing the concentrations of micropollutants, including
endocrine-disrupting compounds (EDCs), which notoriously evade traditional wastewater treatment
technologies and are found even in tertiary-treated effluent. For WWTPs practicing deep-well
injection or surface-water discharge, EDCs in the treated effluent are discharged into groundwater or
the aquatic environment where humans and wildlife may potentially suffer the effects of chemical
exposure. In the current laboratory-scale study, we tested a bench-top electrocoagulation (EC) unit
utilizing aluminum blades for the removal of six estrogenic EDCs [estrone (E1), 17β-estradiol (E2),
estriol (E3), 17α-ethinylestradiol (EE2), bisphenol-A (BPA), and nonylphenol (NP)]. Samples of
municipal wastewater influent and tertiary-treated effluent were spiked with the six EDCs in order
to test the removal efficiency of the EC unit. The mean concentration of each EDC component was
statistically lower after EC treatment (removal range = 42%–98%). To our knowledge, this is the
first study to investigate aluminum electrocoagulation for removal of these specific EDCs, including
nonylphenol (without the ethoxylate chain), as well as natural and synthetic estrogens.
Keywords: micropollutant; endocrine disruption; chemical contaminants; pharmaceutical; water
treatment; wastewater; estrogen; electrocoagulation
1. Introduction
Micropollutants are chemical contaminants found in the aquatic environment in the µg/L (ppb)
or ng/L (ppt) concentration range that are considered to be potential threats to environmental
ecosystems [1,2]. Both domestic and industrial wastewaters contain micropollutants, which are not
entirely removed by conventional wastewater treatment plant (WWTP) processes and are, therefore,
continually discharged into the aquatic environment [3]. The origin of micropollutant contamination
is predominantly anthropogenic and the aquatic environment becomes the final resting place for the
majority of these chemical compounds [4,5].
Endocrine-disrupting compounds (EDCs) are an important class of micropollutants that are
defined as exogenous chemicals, or mixtures of chemicals, that can interfere with any aspect of
hormone action [6]. EDCs are a particularly troublesome subset of micropollutants, due to their diverse
nature, persistence in the environment, and ability to cause metabolic and reproductive disturbances
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at very low concentrations. EDCs can enter the aquatic environment directly (e.g., through effluent
discharge) or indirectly (e.g., storm-water runoff), but the major transport of EDCs to the aquatic
environment is through treated and untreated municipal wastewater discharge to rivers, streams, and
surface waters [1,7,8]. Potable water resources, including both surface water and groundwater, can
become contaminated through surface-water discharge or deep-well injection of WWTP effluent [4].
Effects of EDCs on wildlife (invertebrates, fish, amphibians, reptiles, birds, and mammals) include:
abnormal blood hormone levels, altered gonadal development (e.g., imposex and intersex), induction
of vitellogenin gene and protein expression in juveniles and males, masculinization/feminization,
hermaphroditism, and decreased fertility and fecundity [9–12].
Estrogenic EDCs specifically target estrogen signaling. These include natural steroidal estrogens,
synthetic estrogens, and industrial compounds which mimic estrogen. 17β-estradiol (E2) is the primary
natural estrogen and has the greatest potency. Estrone (E1), a metabolite of E2, is a slightly weaker
estrogen. Estriol (E3), considered to be the final metabolite, is the weakest natural estrogen, with
only 10% of E2’s potency. 17α-ethinylestradiol (EE2) is the synthetic steroidal estrogen component
of contraceptives [13]. The overall estrogenicity of EE2 in effluent overshadows that of both E1 and
E2 combined, due to its high estrogenic potency [14]. Bisphenol-A (BPA) is a monomer used in
industry to produce lacquers, food-can liners, and thermal paper [15]. It has high water solubility and
enters WWTPs through industrial discharges and leaching from BPA-based products. Nonylphenol
(NP) is the persistent and estrogenic final product of the biodegradation of the non-ionic surfactant
nonylphenol ethoxylate (NPEO) [16].
Conventional WWTP processes are designed primarily for the removal of organic matter,
nitrogen, phosphorus, and pathogens; therefore, it is not surprising that the effluent from conventional
WWTPs still contains EDCs at levels ranging from a few ng/L to several µg/L, which are sufficient
to cause endocrine disruption in some species [17]. The concentrations of EDCs in WWTP influent
vary according to geographic location and population served, while the level of EDC removal during
treatment varies according to the WWTP processes employed [18,19]. Monitoring studies have
demonstrated that some wastewater treatment processes are more effective than others for reducing
EDCs and ultimately a combination of approaches may be necessary to reduce this diverse class of
micropollutants. This manuscript focuses solely on the potential of electrocoagulation (EC) for EDC
removal in municipal wastewater, since the efficacy of various WWTP processes (e.g., biological
treatment with activated sludge, activated carbon treatment, nanofiltration, reverse osmosis, ozonation,
and advanced oxidative processes) for reducing EDC concentrations has been reviewed extensively [20–22].
Electrocoagulation technology reduces contaminant levels by passing an electrical current
through water, which generates coagulant precursors by electrolytic oxidation of sacrificial anode
material—usually aluminum or iron. During the EC process, amorphous insoluble polymeric metal
hydroxides and oxides are formed, which adsorb pollutants (particulate and dissolved) during
precipitation, making them easily separable [23,24] (Figure 1). The most widely used electrode
materials, aluminum and iron, are both inexpensive and effective against a wide range of pollutants,
including soluble organic pollutants [25,26]. Patented over a century ago, EC has a long history as
a water treatment technology. However, EC was abandoned by the 1930s due to high operation
costs, as well as the availablilty of inexpensive chemicals for chemical coagulation treatment [27].
Recent technical and design improvements, combined with a growing need for cost-effective water
treatment processes, have led to a re-evaluation of EC technology [27]; however, to our knowledge
no studies have tested the efficacy of EC with aluminum blades for reducing EDCs from municipal
wastewater. This study therefore sought to determine the removal efficiency of a laboratory-scale
electrocoagulation unit with respect to six estrogenic endocrine-disrupting compounds in WWTP
influent and tertiary-treated effluent.
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Figure 1. Representative schematic of water flow and interactions inside the reaction chamber. The 
two black vertical bars represent the electrodes where the power is attached, and the white in between 
them represents the sample solution flowing past the electrodes. Metal dissolution occurs at the anode 
which generates aluminum ions. Reduction reactions occur at the cathode which form hydroxide ions. 
The precipitation reaction occurs when the aluminum and hydroxide ions combine to form aluminum 
hydroxide (dark circles). The aluminum hydroxides form structures which adsorb contaminants 
(dark stars), enabling their removal. 
2. Materials and Methods 
2.1. Electrocoagulation Unit 
The EC unit (Figure 2) is a 110-volt demonstration unit manufactured and supplied by Powell 
Water Systems, Inc. (Centennial, Colorado, USA; United States patent number 7211185 B2). The 
configuration used in this study has been previously examined for its ability to reduce concentrations 
of nutrients, personal care products, and microbial pathogens and indicators [28]. The power source 
is a 110-volt alternating current (AC) to direct current (DC) power converter (allowing direct line 
voltage to be converted from AC to DC) with voltage control. The pump is a Cole-Parmer® 
Masterflex Peristaltic Pump System (Vernon Hills, IL, USA) equipped with a 1/20-horsepower 
unidirectional motor and a separate single-turn speed control. The EC unit chamber (35.6 cm × 5.4 
cm × 2.5 cm) is made of a non-conductive acrylic resin and has a total volume of 487.5 mL. Nine 
aluminum reaction blades (30.5 cm × 2.5 cm × 0.3 cm) were arranged vertically inside the chamber 
with an electrode gap of 3.18 mm. This vertical arrangement promotes a vertical flow of liquid through 
the chamber. The volume of one blade is 24.6 cm3 and the volume of all nine blades equals 221.2 cm3, 
leaving a residual chamber volume of 266.3 mL. The EC unit was operated with a three-lead arrangement 
of electrical connections (power attached to blades 1, 5 and 9; Figure 3) which results in a configuration of 
two anodes and one cathode. The inflow tube measures 1.2 m. 
 
Figure 2. Schematic of laboratory-scale electrocoagulation unit. 
Figure 1. Representative schematic of water flow and interactions inside the reaction chamber.
The two black vertical bars represent the electrodes where the power is attached, and the white
in between them represents the sample solution flowing past the electrodes. Metal dissolution occurs
at the anode which generates aluminum ions. Reduction reactions occur at the cathode which form
hydroxi e ions. The pre ipitation reaction occurs when the aluminum and ydroxide ions combine to
form aluminum hydroxid (dark circles). The aluminum hydroxides form structures which adsorb
contaminants (dark stars), enabling their removal.
2. Materials and Methods
2.1. Electrocoagulation Unit
The EC unit (Figure 2) is a 110-volt demonstration unit manufactured and supplied by Powell
Water Systems, Inc. (Centennial, Colorado, USA; United States patent number 7211185 B2).
The configuration used in this study has been previously examined for its ability to reduce
concentr tions of nutrients, personal care products, and mic bial pathogens nd indicators [28].
The pow source is a 110-volt al rnating current (AC) to direct current (DC) power converter
(allowing direct line voltage to be converted from AC to DC) with voltage control. The pump
is a Cole-Parmer®Masterflex Peristaltic Pump System (Vernon Hills, IL, USA) equipped with
a 1/20-horsepower unidirectional motor and a separate single-turn speed control. The EC unit
chamber (35.6 cm ˆ 5.4 cm ˆ 2.5 cm) is made of a non-conductive acrylic resin and has a total volume
of 487.5 mL. Nine aluminum reaction blades (30.5 cm ˆ 2.5 cm ˆ 0.3 cm) were arranged vertically
inside the chamber with an electrode gap of 3.18 mm. This vertical arrangement promotes a vertical
flow of liqui through the chamber. The volume of one blade is 24.6 cm3 and the volume of all nine
blades equals 221.2 cm3, leaving a residual chamber volume of 266.3 mL. The EC unit was operated
with a three-lead arrangement of electrical connections (power attached to blades 1, 5 and 9; Figure 3)
which results in a configuration of two anodes and one cathode. The inflow tube measures 1.2 m.
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Figure 3. Diagram and close-up picture of the nine aluminum blades showing the electrical 
connections to blades 1, 5, and 9. Anodes are indicated in blue by (+), cathode is indicated in red by 
(−), and arrows show the flow of electrons. 
2.2. Preliminary Tests and Optimization of Parameters 
The parameters used for this laboratory-scale study were chosen based upon a series of tests 
performed to evaluate EDC removal efficiency using different EC conditions and configurations 
(Supplementary Tables S1 and S2). The optimal parameters used for this study (Supplementary  
Table S3) were as follows: aluminum blades as the sacrificial electrodes, three-lead arrangement of 
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tubing. To ensure against cross-contamination between replicates, the EC unit was cleaned in between 
each run to remove any residual EDCs. The EC unit was cleaned by first removing the blades and rinsing 
the unit with tap water. The blades were scrubbed with steel wool in order to remove the build-up of the 
oxidizing layer. The scrubbed blades were then reset and the unit was flushed with 1 L ACS methanol to 
remove residual EDCs and 2 L deionized (DI) water to rinse the unit of residual methanol. Once the unit 
was cleaned, DI water laboratory blanks were passed through the unit (no power) to ensure that no EDCs 
remained in the unit. Polarity reversal of the electrodes was implemented between runs to help prevent 
the build-up of an oxidizing layer on the blade surface. 
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2.2. Preliminary Tests and Optimization of Parameters
The para eters used for this laboratory-scale study were chosen based upon a series of tests
performed to evaluate EDC removal efficiency using different EC conditions and configurations
(Supplementary Tables S1 and S2). The optimal parameters used for this study (Supplementary
Table S3) were as follows: aluminum blades as the sacrificial electrodes, three-lead arrangement of
electrical connections, sample retention time of 2 min/L in the EC reaction chamber, volts held in
the range of 85 to 98, and amperes held in the range of 8.5 to 15.5. Inclusion of a precise cleaning
step was important in the preliminary testing, as EDCs were found to “stick” to the walls of the unit
and tubing. To ensure against cross-contamination between replicates, the EC unit was cleaned in
between each run to remove any residual EDCs. The EC unit was cleaned by first removing the blades
and rinsing the unit with tap water. The blades were scrubbed with steel wool in order to remove
the build-up of the oxidizing layer. The scrubbed blades were then reset and the unit was flushed
with 1 L ACS methanol to remove residual EDCs and 2 L deionized (DI) water to rinse the unit of
residual methanol. Once the unit was cleaned, DI water laboratory blanks were passed through the
unit (no power) to ensure that no EDCs remained in the unit. Polarity reversal of the electrodes was
implemented between runs to help prevent the build-up of an oxidizing layer on the blade surface.
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Figure 4.
Water 2016, 8, 128 5 of 15
Water 2016, 8, 128 5 of 15 
 
Figure 4. Illustration of the wastewater treatment processes at South Cross Bayou. Stars indicate the 
points of the raw influent and tertiary-treated effluent samples. 
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the threat of BPA leaching from the Tygon tubing used in the experiment, BPA removal assays were 
conducted separately from the remaining EDCs.  
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Stock standards were made up in methanol and, due to the low water solubility of steroids, were 
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relatively higher concentrations in wastewater, NP and BPA were added at higher levels than the 
estrogens. Three liters of WWTP influent were spiked with the estrogens and nonylphenol after being 
filtered through a 1.5 µm pore size, glass microfiber filter (Whatman 934-AH; Fisher Scientific, Pittsburgh, 
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2.5. Blanks
Fiel blanks were taken at the sample site. Laboratory blanks (DI water spiked with internal
standard) were extracted with each batch of samples. Gas chromatograph -mass spectrometry (GCMS)
instrument blanks (bla k solvent injections) were performed very eig t samples. All EDCs were
undetectable in all the blank samples, including the DI water blanks that were run through the EC
unit in between replicate runs, illustrating the effectiveness of the solvent cleaning step performed
between runs.
2.6. Experimental Design/Electrocoagulation P ocessing
Both raw WWTP influent and tertiary-treated effluent were tested in this study in order to
determine not only if the effectiveness of EC for reducing EDCs is matrix-dependent, but also to
assess the possibility of using EC as a post-treatment addition to traditional WWTPs. Samples were
collected the morning of the experiment in methanol-cleaned, 20 L high-density polyethylen carboys.
Influent s mples were t k n the headwo ks of the plant while effluent samples ere colle ted after
the dechlorination step. After sampling, t e carboys were immediately transported to the lab and
refrigerated at 4 ˝C until processing. In the lab, eight spiked-wastewater replicates (outlined below)
were created. Half of the spiked-wastewater replicates (n = 4) went straight to analysis (pre-EC) and
the other half (n = 4) were processed via electrocoagulation (post-EC). Due to the threat of BPA leaching
from the Tygon tubing used in the experiment, BPA removal assays were conducted separately from
the remaining EDCs.
Since background concentrations in the WWTP influent and effluent were too low to
demonstrate significant removal pot ntial by th EC unit, it was nec ssary to spike both with EDCs.
High concentrations of EDC spikes w re used to challenge the effic e cy of the EC unit for removal.
Stock standards were made up in methanol and, due to the low water solubility of steroids, were
added to the pre-EC samples via methanol. Spikes were prepared for the four estrogens (estrone (E1),
estradiol (E2), estriol (E3), ethinylestradiol (EE2)) at a concentration of 5 µg estrogen/250 µL methanol.
Spikes were also prepared for the two industrial compounds (bisphenol-A (BPA) and nonylphenol
(NP)) at a concentration of 20 µg industrial compound/250 µL methanol. Due to their relatively
higher concentrations in wastewater, NP and BPA were added at higher levels than the estrogens.
Three liters of WWTP influent were spiked with the estrogens and nonylphenol after being filtered
through a 1.5 µm pore size, glass microfiber filter (Whatman 934-AH; Fisher Scientific, Pittsburgh, PA,
USA). This resulted in a final concentration of 1.7 ppb for the estrogens in wastewater and 6.7 ppb
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for the industrial compounds in wastewater. Similarly, 3 L of WWTP effluent were spiked with the
aforementioned EDCs.
In order to test the removal efficiency of the EC unit, 3 L of spiked WWTP influent (n = 4) and
effluent (n = 4) were separately processed through the EC unit via a recirculation method, where
the original sample was passed through the unit, discharged from the unit and then circulated back
through the unit. The pump speed was set at eight which corresponded to a retention time of 2 min/L.
The voltage fluctuated between 85 and 98 and the ampere readings fluctuated between 9 and 15.5
during EC treatment. Once the sample was collected from the EC unit, it was allowed to sit while
coagulation began. After approximately 20 minutes, the EC-treated sample was filtered through
two Whatman Grade 1 filters (pore size 11 µm) in order to separate the flocculent (sludge phase) from
the treated water (aqueous phase). The final volume captured for analysis was 1 L.
For the BPA experiment, 3 L of WWTP influent (n = 4) and effluent (n = 4) were spiked with BPA
and processed through the EC unit via a one-time flow-through method where the sample would not
retouch the Tygon inflow tube (manufactured with BPA). Since the temperature of the EC effluent
could get as hot as 69 ˝C, a one-time flow-through method was essential in order to prevent BPA
leaching from the Tygon inflow tube. The pump speed was set at 2.2 which still corresponded to
a retention time of 2 min/L. The voltage fluctuated between 94 and 98 and the ampere readings
fluctuated between 8.5 and 14.5. The post-EC samples were collected as previously described after the
flocculent was separated from the treated water.
2.7. Solid Phase Extraction
In order to determine the concentration of EDCs, the pre-EC and post-EC 1 L samples were
processed via solid phase extraction (SPE) within 24 hours and subsequently analyzed via GCMS.
An Evolute ABN (Acid, Base, Neutral) column (6 mL/200 mg, Biotage; Charlotte, NC, USA) was
conditioned with methanol and equilibrated with DI water. The sample was then loaded onto the
column at a flow rate of 15 mL/min using a large volume extraction tank (Biotage, USA) and an SPE
vacuum pump. EDCs retained in the column matrix were eluted with 6 mL methanol. The eluate
was spiked with 5 µg internal standard and evaporated to dryness under a gentle stream of nitrogen.
Recoveries of all compounds were documented and accounted for in the final quantification.
2.8. Determination of EDC Concentrations
Samples were derivatized to their trimethylsilyl ethers by adding 250 µL of BSTFA + 1% TMCS
and 250 µL of pyridine, followed by heating in a 60 ˝C water bath for 40 min in order to drive the
derivatization reaction to completion. Samples were then transferred to a 2 mL vial via low volume
insert for analysis by GCMS. The GCMS system (Bruker; Fremont, CA, USA) consisted of a Varian
3800 gas chromatograph coupled with a Varian 320 mass spectrometer. The GCMS was equipped with
a 30 m ˆ 0.25 mm (internal diameter) ZB-5MS (Phenomenex; Torrance, CA, USA) fused silica capillary
column coated with a 5% phenyl arylene/95% dimethylpolysiloxane stationary phase (film thickness
0.25 µm). Helium (high purity) was used as the carrier gas at a flow rate of 1 mL/min. The GC
oven temperature was programmed to begin at 150 ˝C with an initial hold time of 2 min, followed by
a temperature ramp of 6 ˝C/min until reaching 310 ˝C. The final hold time was 6 min for a total run
time of 35 min. The MS was operated in selected ion monitoring (SIM) mode for quantitative analysis
using electron impact (EI) ionization at 70 electron volts (eV). The dwell time per atomic mass unit
(amu) was 0.5 seconds, and the quantitative and confirmatory ion fragments are outlined in Table 1.
Method detection limits (MDLs) were based on standard deviate protocol and were evaluated using
GCMS at a signal-to-noise ratio between 5 and 10. Nine replicates were spiked near the detection
limit (S/N between 5 and 10) and carried through the entire analytical procedure. Based upon the
variability of the replicates, the MDL for each compound was calculated as the standard deviation
multiplied by the t-value for nine observations (eight degrees of freedom; t-value = 2.896). MDLs were
in the range of 1 to 3 ng/L (Table 1).
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Table 1. Characteristics of estrogenic endocrine-disrupting compounds and internal standard.
Compound Type Retention Time(min) Quantitative Ion
Confirmatory
Ion(s)
Method Detection
Limit (ng/L) Structure
Estrone (E1) Naturalestrogen 21.9 342 218, 257 2
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Table 1. Cont.
Compound Type Retention Time(min) Quantitative Ion
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Ion(s)
Method Detection
Limit (ng/L) Structure
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2.9. Statistical Analysis
SAS version 9.4 (SAS Institute Inc.; Cary, NC, USA) was used for statistical analysis of data
retrieved from GCMS analysis. All values are reported as mean ˘ SD. MANOVA was run with four
groups (raw influent not treated, raw influent EC-treated, effluent not treated, and effluent EC-treated)
with the 6 quantitative variables (E1, E2, EE2, E3, BPA, and NP) using Pillai’s Trace statistic. If the
MANOVA results showed statistical significance, then post hoc testing was run between the raw influent
groups (not treated and EC-treated) and between the effluent groups (not treated and EC-treated) for
each EDC.
3. Results and Discussion
3.1. Removal of EDCs from Spiked-WWTP Influent by EC
The mean removal achieved for each of the six EDCs from spiked-WWTP raw influent samples
is illustrated in Figures 5 and 6. The mean removal efficiency ranged from 56% (estriol, E3) to 81%
(nonylphenol, NP). Furthermore, each EDC post-EC had a statistically lower mean concentration than
pre-EC (Table 2) obtained from the post hoc test of the statistically significant MANOVA result. NP was
removed to the greatest extent (81% removal). Other studies [29,30] have investigated the removal of
nonylphenol ethoxylates (NPEOs), but to our knowledge this is the first study to test the removal of
the estrogenic breakdown product, NP, by electrocoagulation.
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Table 2. Percent removal of endocrine-disrupting compounds from spiked-WWTP raw influent samples.
EDC Mean Pre-ECConc ˘ SD (µg/L)
Mean Post-EC
Conc ˘ SD (µg/L) Test Statistic p Value % Removal
E1 7 ˘ 0.3 3 ˘ 0.1 F = 1194.45 <0.0001 61
E2 5 ˘ 0.2 2 ˘ 0.1 F = 954.56 <0.0001 63
EE2 5 ˘ 0.1 2 ˘ 0.1 F = 2079.79 <0.0001 64
E3 6 ˘ 0.2 3 ˘ 0.1 F = 1021.31 <0.0001 56
BPA 23 ˘ 1 8 ˘ 4 F = 85.15 <0.0001 66
NP 17 ˘ 2 3 ˘ 1 F = 133.28 <0.0001 81
E3 was removed to a lesser extent (56%) than any of the other compounds, which could be
explained by its physico-chemical properties and its lower affinity for sorption onto organic solids.
The octanol-water partition coefficient (Kow) describes the partitioning behavior of a compound
between water and organic phases. The higher the Kow, the more hydrophobic the compound and the
more likely it is to be removed from solution. Most EDCs are hydrophobic compounds with similar
log Kow values (e.g., log Kow values of 3.5–4). Since these hydrophobic compounds readily adsorb
onto sludge solids, sorption plays an important role in their removal from the aqueous phase [31].
However E3, with its three hydroxyl groups, is only weakly hydrophobic (log Kow = 2.45–2.81) and is,
therefore, less apt to bind to sludge [32]. Due to this, E3 likely does not have the same affinity for the
flocculent produced during EC treatment. With more E3 in the aqueous phase (i.e., not bound to the
EC flocculent), more of it withstands filtration and passes into the EC-treated water sample.
BPA concentrations were reduced by 66%, which is important since BPA is one of the most highly
produced chemicals in the world. BPA enters the WWTP at levels in the low ug/L range (concentration
can be greatly increased if industrial discharges contribute to WWTP influent). Our findings support
those of Govindaraj, et al. [33] who achieved 65% removal of BPA from aqueous solutions using
aluminum electrocoagulation. Compared with NP, BPA is a more polar compound which explains its
lower levels of removal. BPA does not tend to adsorb to sludge particles/sediment as much as NP.
Estrone and estradiol had similar removal levels at 61% and 63%, respectively. Of the natural
estrogens, E2 has the greatest potency yet E1 still retains high estrogenicity. For this reason, it is
important that both of these natural estrogens are reduced to a significant extent at the level of the
WWTP. Since E1 retains estrogenicity and the amount of E1 discharged from WWTPs is more than
ten times greater than that of E2, it has been suggested that E1 is the most important natural EDC [3].
3.2. Removal of EDCs from Spiked-WWTP Tertiary-Treated Effluent by EC
The mean removal achieved for each of the six EDCs from tertiary-treated effluent samples is
illustrated in Figures 7 and 8. The removal efficiency ranged from 42% (BPA) to 98% (NP), and again
each EDC post-EC had a statistically lower mean concentration than pre-EC (Table 3) obtained from
the post hoc test of the statistically significant MANOVA result.
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Higher levels of removal were achieved for NP (98%) in the effluent than in the raw influent
samples. However, even with 98% removal, the amount of NP in the final treated sample may still retain
estrogenicity. This will be an important question in future testing of EC at environmentally-relevant
concentrations. The amount of NP in our post-EC sample, 367 ng, may still be high enough to cause
endocrine disruption due to the high initial spike. However, if 98% removal is still achieved at
environmentally-relevant concentrations, it will be important to determine if the post-EC concentration
is estrogenic or not. In vitro bioassays have the advantage of screening for estrogenicity without a priori
knowledge of the pollutant p sent, and this will be a useful tool in future EC testing.
EE2 was removed to a high extent (68%) which again is important considering the potent
estrogenicity of this compound in the environment as well as its recalcitrant behavior concerning most
treatment processes. Estriol was reduced by 53% which is comparable to the raw influent. A lower
removal was seen with BPA (42%) than in the raw influent samples. Estrone and estradiol were
similarly removed (62% and 60%, respectively) as in the raw influent samples. Since the combination
of E1 and E2 contribute largely to the estrogenicity of a sample, their removal is of considerable
importance in water treatment processes.
3.3. Implementation Considerations and Concluding Remarks
A detailed comparison of the EDC removal results obtained using EC with typical removal levels
achieved using other existing technologies has been presented in Cook et al. [34]. hile it is clear that
additional technologies are needed to reduce micropollutant concentrations, the decision to implement
EC treatment requires a cost-benefit analysis, with the main costs of EC being energy consumption [35]
and consumable blade materials. EC utilizes fairly simple equipment and can be easily integrated
into existing WWTPs without extensive reorganization of the plant’s structure and design. The lack of
moving parts reduces the required maintenance [23], and the unit can be inserted into any point in the
WWTP process, since the effectiveness of EC for reducing EDCs in this study did not depend on the
matrix (water) type. For WWTPs that utilize tertiary treatments, like ozonation or filtration, EC could
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be incorporated as an additional pre-cleaning step before tertiary treatment. The effects of EC (e.g.,
reducing the amount of metal ions, heavy metals, colloids, oil wastes, dyes, suspended particles, etc.)
would produce an effluent amenable to tertiary treatment and should reduce the fouling of these latter
steps [25,36]. For WWTPs with no tertiary treatment, the EC process could be used to coagulate the
raw sewage before going into the existing plant clarification unit. Not only would it reduce levels of
chemical oxygen demand, turbidity and many contaminants [37], but it would also have the added
benefit of EDC removal. EC can also be used to replace conventional chemical coagulation in plants
where that technology is in use, since EC reduces the direct handling of corrosive chemicals and does
not produce any secondary pollution caused by added chemical substances [35,37]. Furthermore, EC
is a low-sludge producing technique, and the sludge formed tends to be readily settleable and easy to
de-water [23].
Future testing should include environmentally-relevant concentrations in WWTP influent and
effluent. Since these concentrations, especially for the natural and synthetic estrogens, are on the
order of low ng/L, detection limits of analytical instruments used will need to be pushed to the pg/L
range. Bioassays will also be an important tool in future testing to determine the final estrogenicity
of samples due to the fact that pollutants rarely occur as isolated compounds in environmental
matrices, but rather in complex mixtures where pollutants can act synergistically, antagonistically,
or additively. Finally, future research should continue to explore the potential synergy of combining
EC with additional emerging treatment technologies. For example, a recent study demonstrated that
combining electro-enzymatic catalysis with EC results in efficient removal of BPA from water [38].
4. Conclusions
In conclusion, the electrocoagulation of wastewater (WWTP raw influent and tertiary-treated
effluent) spiked with six estrogenic EDCs was tested for efficiency of removal using a laboratory-scale
unit. EC, with the optimal operating parameters determined in this study, enabled statistically
significant removal of all EDCs in both WWTP raw influent (56%–81% removal) and tertiary-treated
effluent (42%–98% removal). Although determining the mechanisms responsible for EDC removal
is beyond the scope of this study, it is likely that these compounds were removed through sorption
onto the amorphous aluminum hydroxide flocs followed by filtration. These flocs, termed “sweep
flocs”, have large surface areas which promote rapid adsorption of soluble organic compounds [39].
In this study, all samples were spiked with EDCs to challenge the EC instrument with removal of
significant quantities of contaminants. Overall, this study demonstrated that aluminum EC can reduce
EDC concentrations in municipal wastewater influent and effluent, a property that merits further
exploration in anticipation of future regulations regarding EDC discharge into the environment.
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Abbreviations
The following abbreviations are used in this manuscript:
WWTP Wastewater treatment plant
EDC Endocrine-disrupting compound
EC Electrocoagulation
E1 estrone
E2 17β-estradiol
E3 estriol
EE2 17-ethinylestradiol
BPA bisphenol-A
NP nonylphenol
NPEO nonylphenol ethoxylate
BSTFA N, O-bis(trimethylsilyl)trifluoroacetamide
DI deionized
GCMS gas chromatography-mass spectrometry
MDL method detection limit
TMCS trimethylchlorosilane
EI (electron impact)
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